ReCept Pharmacy to Distribute Otezla® (apremilast): The First FDA Approved Oral Medication for the Treatment of Psoriatic

  ReCept Pharmacy to Distribute Otezla® (apremilast): The First FDA Approved
     Oral Medication for the Treatment of Psoriatic Arthritis for Adults

PR Newswire

FORT WORTH, Texas, April 14, 2014

FORT WORTH, Texas, April 14, 2014 /PRNewswire/ --ReCept announces that it is
among a select group of specialty pharmacies selected by Celgene to distribute
Otezla® (apremilast), a new medication for the treatment of psoriatic
arthritis. Otezla® is an oral small-molecule which works by blocking the
enzyme phosphodiesterase 4 to reduce swelling in joints and improve physical
function in a form of arthritis that afflicts psoriasis sufferers. Approved by
the FDA on March 21, 2014 and available for dispensing on April 9, ReCept has
immediate access to dispense Otezla® at initial launch.

According to the National Psoriasis Foundation, approximately 10 to 30 percent
of people with psoriasis will develop psoriatic arthritis. Psoriasis is the
most prevalent chronic inflammatory disease in the U.S.

Otezla® is the first oral therapy approved to treat active psoriatic
arthritis. In clinical trials, Otezla® demonstrated the ability to reduce the
signs and symptoms of psoriatic arthritis. Patients treated with Otezla®
showed improvement in signs and symptoms of PsA, including tender and swollen
joints and physical function, compared to placebo.

As a specialty pharmacy, ReCept is committed to providing patients with
optimal outcomes for psoriatic arthritis. Through the use of robust
medications like Otezla® in combination with ReCept's 'making people feel
better' clinical approach to patient management, patients are able to take
full advantage of treatment and maximize clinical benefit.

About ReCept Pharmacy

As a leader in the Specialty Pharmacy industry in the Southwest, ReCept cares
for patients throughout a regional network of pharmacies located in Texas.
With over 35 years of experience in providing pharmacy care, ReCept employs a
knowledgeable, dedicated clinical staff to manage patients with complex
chronic conditions. ReCept specializes in serving patients and their treating
physicians within the therapeutic classes of Autoimmune, Hepatitis, HIV,
Oncology, Compounding and Pain Management. Taking a holistic approach to
patient management, ReCept understands specific disease states, their
treatments and the effects those treatments have on individual patients. An
avid commitment to keep patients adherent and compliant with their treatment
regimen is ongoing. The ReCept corporate mission is simple: "To make people
feel better" and improve their overall quality of life. For additional
information on ReCept Pharmacy, please visit: www.receptrx.com

SOURCE ReCept Pharmacy

Website: http://www.receptrx.com
Contact: Daryl Newman, 1-972-632-7485, dnewman@receptrx.com
 
Press spacebar to pause and continue. Press esc to stop.